新型冠状病毒

US criticised for rolling out Covid boosters without human trials

Some health experts say vaccination campaign risks undermining public trust

Health experts have warned that the US decision to roll out new Covid boosters without clinical testing on humans risks denting public trust and increasing hesitancy about vaccines.  

The Joe Biden administration is using the bivalent boosters, which contain the original Covid strain and the genetic code of the Omicron sub-variants BA4 and BA5, to vaccinate more Americans against the virus.

It has bought 171mn doses of the BioNTech/Pfizer and Moderna boosters for $5bn and fast-tracked their authorisation before human trials are complete, hoping that they provide better protection against the dominant variants than existing Covid vaccines.

您已阅读10%(645字),剩余90%(5867字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×